Denali Advisors LLC raised its stake in shares of National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report) by 74.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 22,900 shares of the company’s stock after purchasing an additional 9,800 shares during the period. Denali Advisors LLC owned 0.15% of National HealthCare worth $4,840,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in NHC. BlackRock Inc. acquired a new position in National HealthCare in the second quarter valued at approximately $417,602,000. Morgan Stanley Institutional Investment Advisors LLC grew its position in shares of National HealthCare by 38.6% during the 4th quarter. Morgan Stanley Institutional Investment Advisors LLC now owns 1,038,787 shares of the company’s stock worth $142,407,000 after buying an additional 289,566 shares during the period. First Trust Advisors LP increased its stake in shares of National HealthCare by 556.4% in the 3rd quarter. First Trust Advisors LP now owns 207,483 shares of the company’s stock valued at $25,211,000 after acquiring an additional 175,873 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of National HealthCare in the 2nd quarter valued at $25,854,000. Finally, Arrowstreet Capital Limited Partnership lifted its position in shares of National HealthCare by 407.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 75,257 shares of the company’s stock valued at $12,019,000 after acquiring an additional 60,420 shares during the period. Institutional investors own 56.44% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the company. Royal Bank Of Canada upgraded National HealthCare to a “hold” rating in a report on Monday, May 18th. Robert W. Baird raised National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. The Goldman Sachs Group upgraded National HealthCare to a “strong-buy” rating in a report on Monday, May 18th. Finally, BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, National HealthCare presently has a consensus rating of “Buy”.
National HealthCare Stock Down 0.1%
Shares of NHC opened at $234.04 on Thursday. The business’s 50-day moving average price is $215.00 and its 200-day moving average price is $186.44. National HealthCare Corporation has a twelve month low of $109.53 and a twelve month high of $239.19. The stock has a market cap of $3.67 billion, a PE ratio of 26.33 and a beta of 0.61.
National HealthCare (NYSEAMERICAN:NHC – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%. The business had revenue of $408.03 million for the quarter.
National HealthCare Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. National HealthCare’s dividend payout ratio (DPR) is currently 61.89%.
Insider Activity
In other news, Director Lisa Piercey acquired 949 shares of the business’s stock in a transaction on Monday, June 1st. The shares were acquired at an average cost of $184.26 per share, with a total value of $174,862.74. Following the transaction, the director owned 949 shares in the company, valued at $174,862.74. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 13.92% of the company’s stock.
About National HealthCare
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Further Reading
- Five stocks we like better than National HealthCare
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.
